JPRN-UMIN000004477已完成未知
Efficacy and safety of hydroxychloroquine for systemic/cutaneous lupus erythematosus or Sjogren's syndrome patients with annular erythema on the face and/or trunk - Hydroxychloroquine for systemic/cutaneous lupus erythematosus or Sjogren's syndrome with annular erythema
Kanazawa University Graduate School of Medical Science0 个研究点目标入组 10 人开始时间: 2010年11月1日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 10
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 75years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1. Patients with current or previous history of retinopathy. 2. Patients unable to take or unsupplied with 4-aminoquinoline. 3. Body weight is less than 30 Kg. 4. History of pregnancy or lactation. 5. Other patients who were judged to be ineligible for the study by an attending physician.
研究者
相似试验
已完成
3 期
study of hydroxychloroquine in comparison with pioglitazone in patients with type II diabetes mellitusCTRI/2009/091/001036Ipca Laboratories Limited267
尚未招募
3 期
Efficacy of hydroxychloroquine in graves disease in addition to antithyroid drugs.CTRI/2023/07/054894IPQA laboratories
Unknown
不适用
A Clinical Study to Assess and Compare the Efficacy and Safety of Hydroxychloroquine and Teneligliptin in Type 2 Diabetes Patients with Non-proliferative Diabetic RetinopathyCTRI/2020/04/024637IPGMER and SSKM Hospital
进行中（未招募）
不适用
Efficacy of the treatment with hydroxychloroquine in non responders HIV-infected HAART-treated patients - NDHIV infection (immunological nonresponders).MedDRA version: 9.1Level: LLTClassification code 10008922EUCTR2009-012499-28-ITAZIENDA OSPEDALIERA L. SACCO (A.O. DI RILIEVO NAZIONALE)40
进行中（未招募）
不适用
Evaluation of the efficacy of hydroxychloroquine in decreasing immune activation in asymptomatic HIV-infected patients (HCQ-01) - Hydroxychloroquine studyHIV infectionMedDRA version: 9.1Level: LLTClassification code 10020161Term: HIV infectionEUCTR2007-005057-36-GBMedical Research Council